As traditional biomedical research and data science have converged, we have seen an influx of patent application filings in this newly developing space. The preparation and prosecution of these cross-disciplinary patent applications have posed unique challenges and there remains a great deal of uncertainty and confusion around certain patentability challenges both in the United States and the European Union. In this highly informative program, our panel of examiners from the US Patent Office and the European Patent Office will do a deep dive into the roadblocks that precision medicine and bioinformatics patent applications can face. We will also cover the main differences between the EPO and the USPTO and address how to best navigate them in the current legal environment.
Thursday, September 21, 2017
9:30 a.m. – 1:30 p.m.
Agenda:
9:30 a.m. – 10:00 a.m. Registration/Light Breakfast
10:00 a.m. – 12:30 p.m. Program/Q&A
12:30 p.m. – 1:30 p.m. Lunch Buffet
Location:
Fenwick & West
Silicon Valley Center
801 California Street
Mountain View, CA 94041
Webinar Available
Presenters:
Marjorie Moran, Supervisory Patent Examiner, USPTO
Eve-Marie Mayer-Martin, Director, Healthcare/Bioinformatics, EPO
Matthias Hilbig, Examiner, Healthcare/Bioinformatics, EPO
Georg Wimmer, Examiner, Healthcare/Bioinformatics, EPO
Enrique Molian Galan, Director, Biotech, EPO
Kevin Kabler, Associate, Fenwick & West LLP
Andrew Whitehead, Associate, Fenwick & West LLP
Frances Salisbury, Partner, Mewburn Ellis LLP